ClinicalTrials.gov
 Home    Search    Study Topics    Glossary  
 

  Full Text View  
  Tabular View  
  Contacts and Locations  
  Related Studies  
The Effect of Positive Airway Pressure on Heart Rate Variability

This study is ongoing, but not recruiting participants.

Sponsored by: Christiana Care Health Services
Information provided by: Christiana Care Health Services
ClinicalTrials.gov Identifier: NCT00289666
  Purpose

This study is designed to determine the effect of continuous positive airway pressure (CPAP) or bi-level positive airway pressure (BiPAP) on heart rate variability (HRV) in patients with obstructive sleep apnea (OSA).


Condition
Obstructive Sleep Apnea

MedlinePlus related topics:   Sleep Apnea  

U.S. FDA Resources

Study Type:   Observational
Study Design:   Case-Only, Prospective
Official Title:   A Prospective Study to Determine the Effect of Positive Airway Pressure on Heart Rate Variability in Individuals With Obstructive Sleep Apnea

Further study details as provided by Christiana Care Health Services:

Biospecimen Retention:   Samples Without DNA

Biospecimen Description:

Serum, Plasma, Urine


Estimated Enrollment:   38
Study Start Date:   July 2003
Estimated Study Completion Date:   August 2008

 Show Detailed Description

  Eligibility
Ages Eligible for Study:   18 Years to 75 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample

Study Population

Tertiary Care


Criteria

Inclusion Criteria:

  • Individuals aged 18-75 years old.
  • Individuals with diagnosed OSA.

Exclusion Criteria:

  • 1. Individuals who are receiving treatment for OSA, excluding those being treated by weight loss.

    2. Individuals who have had pharyngeal surgery (i.e., uvulopalatopharyngoplasty).

    3. Individuals who have arterial oxygen desaturation episodes or apneic episodes not felt to be due to OSA.

    4. Individuals whose treatment dosage changes 2 months prior to, or during, the study for antihypertensive and antidiabetic medications and the following medications that may affect the autonomic nervous system: anti-tuberculosis drugs, nitrofurantoin, metronidazole, chloramphenicol, perhexiline maleate, cordarone, clofibrate, tricyclic antidepressants, phenytoin, barbiturates, neuroleptic drugs, antiparkinsonism drugs, and nitrated drugs.

  Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00289666

Locations
United States, Delaware
Christiana Care Health Service    
      Newark, Delaware, United States, 19713

Sponsors and Collaborators
Christiana Care Health Services

Investigators
Principal Investigator:     Raelene E Maser, PhD     University of Delaware    
  More Information

Responsible Party:   Christiana Care Health Services ( M James Lenhard, MD )
Study ID Numbers:   23011
First Received:   February 9, 2006
Last Updated:   January 16, 2008
ClinicalTrials.gov Identifier:   NCT00289666
Health Authority:   United States: Institutional Review Board

Keywords provided by Christiana Care Health Services:
Sleep Disorder  
CPAP  

Study placed in the following topic categories:
Sleep Apnea Syndromes
Apnea
Respiration Disorders
Sleep Apnea, Obstructive
Dyssomnias
Signs and Symptoms, Respiratory
Sleep Disorders
Sleep Disorders, Intrinsic

Additional relevant MeSH terms:
Signs and Symptoms
Respiratory Tract Diseases
Nervous System Diseases

ClinicalTrials.gov processed this record on July 03, 2008




Links to all studies - primarily for crawlers